The DGAT1 inhibitor Pradigastat Decreases Chylomicron Secretion and Prevents Postprandial Triglyceride Elevation in Humans
Charles D. Meyers, B.N. Dardik, Rocheford Erik, Renee Commerford, Pan Meihui, Brian K. Hubbard(Broad Institute), Michael H. Serrano‐Wu(Broad Institute), Lisha Li(Fudan University), Jin Chen(University of Electronic Science and Technology of China), Ricardo E. Chatelain, Ahmed Amer, Meg Brousseau
Cited by 24
Related Papers
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation
|Stem Cell Research & Therapy|2020|213
Identification of Hepatitis C Virus NS5A Inhibitors
|Journal of Virology|2009|196
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
|ACS Medicinal Chemistry Letters|2011|86